McMaster University dean receives prestigious award in Germany

[img_inline align=”” src=”http://padnws01.mcmaster.ca/images/kelton.jpg” caption=”Dean and Vice-President of the Faculty of Health Sciences, Dr. John Kelton”]

Dr. John Kelton, dean and vice-president of the Faculty
of Health Sciences at McMaster University, is the first North American physician
to receive Germany's top award in transfusion medicine.

Dr. Kelton, who is also dean and professor of the Michael G. DeGroote School
of Medicine, was given the prestigious Karl Landsteiner award from the German
Society of Transfusion Medicine and Immunohematology this week for his contributions
in the field. The award has been bestowed biennially for more than 30 years.

At the award ceremony in Mannheim, Germany, Dr. Kelton spoke about his work as both a basic scientist and clinical researcher specializing in platelet
and bleeding disorders. The hematologist is known internationally for his leading
edge bench to bedside translational research which has changed
the management of many patients around the world, most notably pregnant women
with platelet disorders and their children. In particular, his work has significantly
improved the world's knowledge of heparin-induced thrombocytopenia, including
the development of Argatroban for its treatment.

I'm honoured to be receiving this award in Germany, said
Dr. Kelton. I must admit, however, that knowing that my work has led
to better care for patients world-wide, particularly pregnant women who have
blood complications, is continuously a pleasure. Knowing you're helping
people is the best part about being a physician or researcher.

His work has led to many national and international awards for research excellence,
including induction as a Fellow of the Royal Society
of Canada; the Jean-Julliard Award from the International
Society of Blood Transfusion; the Emily Cooley Award from the American
Association of Blood Banks and the Bernard L. Schwartz Award from the Scripps
Research Institute. He also holds a Canada
Research Chair in transfusion medicine.

Before joining McMaster University in 1977, Dr. Kelton received specialty and
research training in internal medicine and hematology at Duke
University. He is the author of more than 250 peer-reviewed articles, 80
book chapters, and five books. He has been dean and vice-president of the Faculty
of Health Sciences since 2001.

Republish this Article for Free

Republish this Article

We believe in the free flow of information. This work is licensed under a Creative Commons Attribution-No Derivs 2.5 Canada (CC BY-ND 2.5 CA), so you can republish our articles for free, online or in print.

All republished articles must be attributed in the following way and contain links to both the site and original article: “This article was first published on Daily News. Read the original article.”

[img_inline align="" src="http://padnws01.mcmaster.ca/images/kelton.jpg" caption="Dean and Vice-President of the Faculty of Health Sciences, Dr. John Kelton"]<p>Dr. John Kelton, dean and vice-president of the <a href="http://www.fhs.mcmaster.ca/">Faculty <br />
  of Health Sciences</a> at McMaster University, is the first North American physician <br />
  to receive Germany&#039;s top award in transfusion medicine.</p><br />
<p>Dr. Kelton, who is also dean and professor of the Michael G. DeGroote School <br />
  of Medicine, was given the prestigious Karl Landsteiner award from the German <br />
  Society of Transfusion Medicine and Immunohematology this week for his contributions <br />
  in the field. The award has been bestowed biennially for more than 30 years.</p><br />
<p>At the award ceremony in Mannheim, Germany, Dr. Kelton spoke about his work as both a basic scientist and clinical researcher specializing in platelet <br />
  and bleeding disorders. The hematologist is known internationally for his leading <br />
  edge bench to bedside translational research which has changed <br />
  the management of many patients around the world, most notably pregnant women <br />
  with platelet disorders and their children. In particular, his work has significantly <br />
  improved the world&#039;s knowledge of heparin-induced thrombocytopenia, including <br />
  the development of Argatroban for its treatment. </p><br />
<p>I&#039;m honoured to be receiving this award in Germany, said <br />
  Dr. Kelton. I must admit, however, that knowing that my work has led <br />
  to better care for patients world-wide, particularly pregnant women who have <br />
  blood complications, is continuously a pleasure. Knowing you&#039;re helping <br />
  people is the best part about being a physician or researcher.</p><br />
<p>His work has led to many national and international awards for research excellence, <br />
  including induction as a Fellow of the <a href="http://www.rsc.ca/">Royal Society <br />
  of Canada</a>; the Jean-Julliard Award from the <a href="http://www.isbt-web.org/">International <br />
  Society of Blood Transfusion</a>; the Emily Cooley Award from the <a href="http://www.aabb.org/">American <br />
  Association of Blood Banks</a> and the Bernard L. Schwartz Award from the <a href="http://www.scripps.edu/">Scripps <br />
  Research Institute</a>. He also holds a <a href="http://www.chairs.gc.ca/">Canada <br />
  Research Chair</a> in transfusion medicine.</p><br />
<p>Before joining McMaster University in 1977, Dr. Kelton received specialty and <br />
  research training in internal medicine and hematology at <a href="http://www.duke.edu/">Duke <br />
  University</a>. He is the author of more than 250 peer-reviewed articles, 80 <br />
  book chapters, and five books. He has been dean and vice-president of the Faculty <br />
  of Health Sciences since 2001.</p>

Media Enquiries

Phone: (905) 525-9140 ext. 24073
Email: comms@mcmaster.ca

The Communications and Public Affairs Office is staffed from 8:30 a.m. to 4:30 p.m. Monday to Friday.

The University has a broadcast quality television studio to facilitate live and pre-recorded interviews with media. Learn more about our experts.